Nephroblastoma of the Big Child, a Rare Entity: About a Case.

big child diagnosis imaging nephroblastoma oncology

Journal

Global pediatric health
ISSN: 2333-794X
Titre abrégé: Glob Pediatr Health
Pays: United States
ID NLM: 101670224

Informations de publication

Date de publication:
2022
Historique:
received: 31 05 2022
accepted: 20 06 2022
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 25 11 2022
Statut: epublish

Résumé

Nephroblastoma is a renal blast tumor, the most common malignant renal tumor in children between 1 and 5 years of age. The average age of onset is 3.5 years, rarely occurring in children over 10 years of age. Its treatment is a model of medical-surgical collaboration. The prognostic factors are mainly the stage but recent studies have also shown that the advanced age of the child is a negative prognostic factor. We report a case of a 14-year-old child who presented with pain with swelling of the right hypochondrium, ultrasound showed a heterogeneous right retroperitoneal mass, MRI showed a large retroperitoneal tumor process with a right renal origin, in heterogeneous T2 signal, in T1 hyposignal, diffusion restricted, containing necrotic areas and heterogeneously enhancing after injection, responsible for pyelocalic dilatation and right renal venous thrombosis, extended to the IVC and the right atrium, with adenopathies, suggesting first a sarcoma. The extension workup showed pulmonary nodules of secondary appearance. An echo-guided biopsy was performed and the anatomopathological study confirmed the diagnosis of nephroblastoma.

Identifiants

pubmed: 36420455
doi: 10.1177/2333794X221112637
pii: 10.1177_2333794X221112637
pmc: PMC9677308
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2333794X221112637

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Eur J Cancer. 2006 Sep;42(13):2103-14
pubmed: 16919774
J Clin Oncol. 2003 Sep 1;21(17):3269-75
pubmed: 12947062
Ann Surg. 1999 Feb;229(2):292-7
pubmed: 10024113
Am J Med Genet. 1998 Oct 2;79(4):268-73
pubmed: 9781906
Med Pediatr Oncol. 1993;21(3):172-81
pubmed: 7680412
Eur Radiol. 2008 Apr;18(4):683-91
pubmed: 18193429
J Clin Oncol. 2005 Oct 10;23(29):7312-21
pubmed: 16129848
Med Pediatr Oncol. 2001 Nov;37(5):455-8
pubmed: 11745874
Urol Clin North Am. 2000 Aug;27(3):423-33, viii
pubmed: 10985142
Ann Pathol. 2004 Dec;24(6):516-35
pubmed: 15785400
Prog Urol. 2008 Nov;18 Suppl 7:S298-308
pubmed: 19070807
N Engl J Med. 1994 Sep 1;331(9):586-90
pubmed: 8047084
Pediatr Radiol. 2008 Jan;38(1):2-17
pubmed: 18026723
Pediatr Dev Pathol. 2011 May-Jun;14(3):189-93
pubmed: 21054158

Auteurs

Amine Cherraqi (A)

CHU Ibn Sina, Rabat, Morocco.

Siham El Haddad (S)

CHU Ibn Sina, Rabat, Morocco.

Ola Messaoud (O)

CHU Ibn Sina, Rabat, Morocco.

Rihane El Mohtarim (R)

CHU Ibn Sina, Rabat, Morocco.

Najat Lamalmi (N)

CHU Ibn Sina, Rabat, Morocco.

Maria Elkababr (M)

CHU Ibn Sina, Rabat, Morocco.

Latifa Chat (L)

CHU Ibn Sina, Rabat, Morocco.

Nazik Allali (N)

CHU Ibn Sina, Rabat, Morocco.

Classifications MeSH